Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -10117.00x is 3077% below its 5-year average of -318.43x, near the low end of its 5-year range (-10117.00x–-13.00x).
Reported quarterly interest coverage; no daily interpolation. Q4 FY2025 (2025-12-31): -2256.00x.
INTEREST COVERAGE RATIO
-10117.00x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
-892.06x
INTEREST COVERAGE RATIO AVG 5Y
-318.43x
INTEREST COVERAGE RATIO AVG 10Y
-25.92x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-1034.12%
CURRENT VS 5Y AVG
-3077.11%
CURRENT VS 10Y AVG
-38938.55%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-156996.27%
vs the sector median at left
Exicure, Inc.
Market Cap
$6.88M
Interest Coverage Ratio
-10117.00x
TTM Avg
N/A
3Y Avg
-892.06x
5Y Avg
-318.43x
Market Cap
$6.74M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.07M
Interest Coverage Ratio
-496.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.12M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.61M
Interest Coverage Ratio
N/A
TTM Avg
1010.31x
3Y Avg
1010.31x
5Y Avg
509.98x
Market Cap
$6.60M
Interest Coverage Ratio
-545.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Exicure, Inc. (XCUR) | $6.88M | -10117.00x | N/A | -892.06x | -318.43x |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.74M | N/A | N/A | N/A | N/A |
| KALA BIO, Inc. (KALA)vs › | $7.04M | -11.95x | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.07M | -496.55x | N/A | N/A | N/A |
| Skye Bioscience, Inc. (SKYE)vs › | $7.12M | N/A | N/A | N/A | N/A |
| Longeveron Inc. (LGVN)vs › | $7.15M | N/A | N/A | N/A | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.61M | N/A | 1010.31x | 1010.31x | 509.98x |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.60M | -545.69x | N/A | N/A | N/A |
| Aclarion, Inc. (ACON)vs › | $6.60M | N/A | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.58M | -82777.81x | 11.97x | 11.97x | 11.97x |
Interest Coverage
-10117.0x
Debt/Equity
0.00
Current Ratio
0.56
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-12-31 | -2256.00x |
| 2024-09-30 | -214.33x |
| 2024-06-30 | -205.83x |
| 2022-03-31 | -13.00x |
| 2021-12-31 | -35.67x |
| 2021-09-30 | -50.73x |
| 2021-06-30 | -30.80x |
| 2021-03-31 | -29.72x |
| 2020-12-31 | -29.81x |
| 2020-09-30 | -337.78x |
| 2020-03-31 | 4.17x |
| 2019-12-31 | -51.31x |
| 2019-09-30 | -29.29x |
| 2019-06-30 | -24.55x |
| 2019-03-31 | -30.48x |
| 2018-12-31 | -27.82x |
| 2018-09-30 | -34.49x |
| 2018-06-30 | -34.96x |
| 2018-03-31 | -32.82x |
| 2017-12-31 | -16.61x |
| 2017-09-30 | -9.42x |
| 2017-06-30 | -12.87x |
| 2017-04-01 | -12.17x |
| 2016-12-31 | -26.17x |
| 2016-09-30 | -15.68x |
